Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Articles /     
 
Stemcell implantation to repair damaged heart muscle cells
In the first trail of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery. This trial will be performed in Bristol, UK.

The Bristol trial will test whether the stem cells will repair heart muscle cells damaged by the heart attack, by preventing late scar formation and hence impaired heart contraction.

Dr Raimondo Ascione from the University of Bristol and colleagues at the Bristol Heart Institute (BHI) have been awarded a grant of £210,000 from the British Heart Foundation to conduct the clinical trial.

Source: http://www.bristol.ac.uk/bhi/news-events/sc_grant.html


Tell a friend   |   Print version   |   Send this article

ARTICLES

Pharmacokinetics of quinocetone in ducks after two routes of administrationmembers
Quinocetone (QCT), an antimicrobial growth promoter, is widely used in food-producing animals. However, information about pharmacokinetics (PK) of QCT in ducks still remains unavailable up to now. In this study, QCT and its major metabolites (1-desoxyquinocetone, di-desoxyquinocetone and 3-methyl-quinoxaline-2-carboxylic) in ducks were studied using a simple and sensitive UHPLC-MS/MS assay.

  • Novel antibiotic treatment of zebrafish mycobacteriosismembers
  • Canine mammary tumours as model for hereditary breast cancer susceptibility genes in humansmembers
  • Treatment of corneal ulceration in stranded California sea lions members
  • Effects of substrates and stress on placental metabolismmembers
  • Vaccine regimens against caecal Salmonella Typhimurium colonisation in laying hensmembers
  • Presumptive keratoglobus in a raptormembers
  • Monitored, controlled long-term anaesthesia in broiler chickenmembers
  • Pharmacokinetics of cefovecin in alpacasmembers
  • Use and effect of hand antiseptics in veterinary practicemembers
  • Two dogs with cold agglutinin activitymembers
  • Mechanical ventilation and blood gases and blood pressure in rattlesnakesmembers
  • Infectious haemolytic anemia in an orphaned juvenile female platypus members


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved